Shang YL - Search Results

1

[Analysis of clinical features and prognosis of acute severe autoimmune hepatitis].

Zheng LH, Shang YL, Han ZY, Han Y. Zheng LH, et al. Among authors: shang yl. Zhonghua Gan Zang Bing Za Zhi. 2022 Jan 20;30(1):69-73. doi: 10.3760/cma.j.cn501113-20201106-00603. Zhonghua Gan Zang Bing Za Zhi. 2022. PMID: 35152672 Chinese.

2

Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis.

Zhou L, Zhao X, Han Y, Lu Y, Shang Y, Liu C, Li T, Jin Z, Fan D, Wu K. Zhou L, et al. FASEB J. 2013 Dec;27(12):4929-39. doi: 10.1096/fj.13-233387. Epub 2013 Aug 27. FASEB J. 2013. PMID: 23982143

3

Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer.

Zhou L, Shang Y, Liu C, Li J, Hu H, Liang C, Han Y, Zhang W, Liang J, Wu K. Zhou L, et al. Int J Cancer. 2014 Nov 15;135(10):2329-37. doi: 10.1002/ijc.28883. Epub 2014 Apr 17. Int J Cancer. 2014. PMID: 24706505 Free PMC article.

4

NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.

Lu G, Tian S, Sun Y, Dong J, Wang N, Zeng J, Nie Y, Wu K, Han Y, Feng B, Shang Y. Lu G, et al. Theranostics. 2021 Jan 1;11(5):2460-2474. doi: 10.7150/thno.53169. eCollection 2021. Theranostics. 2021. PMID: 33500736 Free PMC article.

5

Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma.

Tian S, Liu J, Sun K, Liu Y, Yu J, Ma S, Zhang M, Jia G, Zhou X, Shang Y, Han Y. Tian S, et al. Front Oncol. 2021 Jan 26;10:597996. doi: 10.3389/fonc.2020.597996. eCollection 2020. Front Oncol. 2021. PMID: 33575212 Free PMC article.

6

Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis.

Zheng L, Liu Y, Shang Y, Han Z, Han Y. Zheng L, et al. BMC Gastroenterol. 2021 Mar 1;21(1):93. doi: 10.1186/s12876-021-01653-4. BMC Gastroenterol. 2021. PMID: 33648445 Free PMC article.

7

Symptoms Burden and Health-related Quality of Life in Chinese Patients with Primary Biliary Cholangitis.

Liu Y, Tian S, Jia G, Han Z, Guo C, Shang Y, Han Y. Liu Y, et al. J Clin Transl Hepatol. 2021 Dec 28;9(6):860-867. doi: 10.14218/JCTH.2020.00119. Epub 2021 May 6. J Clin Transl Hepatol. 2021. PMID: 34966649 Free PMC article.

8

Immunoglobulin M: A Neglected Serum Biomarker in Treatment-Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase.

Ding D, Xuan G, Hu Y, Yu J, Liu Y, Guo G, Ma S, Yang F, Tian S, Ma G, Chen L, Zhou X, Shang Y, Han Y. Ding D, et al. Hepatol Commun. 2022 Jun;6(6):1403-1412. doi: 10.1002/hep4.1907. Epub 2022 Feb 19. Hepatol Commun. 2022. PMID: 35182047 Free PMC article.

9

[Research progress of osteoporosis in primary biliary cholangitis].

Xuan GY, Xu A, Shang YL, Han Y. Xuan GY, et al. Among authors: shang yl. Zhonghua Nei Ke Za Zhi. 2022 Apr 1;61(4):438-442. doi: 10.3760/cma.j.cn112138-20210518-00351. Zhonghua Nei Ke Za Zhi. 2022. PMID: 35340195 Chinese.

10

A novel immune checkpoint-related gene signature for hepatocellular carcinoma to predict clinical outcomes and therapeutic response.

Tian S, Hu Y, Yang C, Yu J, Liu J, Xuan G, Liu Y, Sun K, Zhang M, Ma S, Shang Y, Zhou X, Han Y. Tian S, et al. Math Biosci Eng. 2022 Mar 10;19(5):4719-4736. doi: 10.3934/mbe.2022220. Math Biosci Eng. 2022. PMID: 35430837 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters